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The method here presented for vaccination against yellow fever was 
devised primarily to interrupt the long series of accidental infections of 
persons  making  laboratory  investigations.  In  the  4½  years  which 
have elapsed since rhesus monkeys first came into use as experimental 
animals in yellow fever studies, there have been reported 32 infections 
with yellow fever in laboratories  devoted to research in this  disease, 
according to Berry and Kitchen (1), and five scientists have lost their 
lives. 
Preliminary Experiments with Other Yellow Fever Vaccines 
The results  of experiments  in this  laboratory and the receipt  of unfavorable 
reports from elsewhere have made us unwilling to recommend the immunization  of 
persons against yellow fever with vaccines prepared by the chemical treatment of the 
virus-containing  tissues of infected monkeys.  Vaccines of this general type have 
been devised by Hindle (2), Aragto (3), Pettit and Stefanopoulo (4), and Monteiro 
(5).  According to Chagas (6), irregular results followed the vaccination of 25,000 
persons by the method of Aragao during the recent epidemic in Rio de Janeiro, and 
failures were also encountered in the experimental vaccination of monkeys.  Okell 
(7) found that a vaccine of the same general type lost its immunizing power rapidly 
on storage,  and this would explain the failures to immunize persons far from the 
place where the vaccine was prepared.  Davis (8) made an experimental  chloro- 
form-treated tissue vaccine which was found, on laboratory test,  to be sometimes 
infective  and  sometimes  without  immunizing  effect.  Burke  and  Davis  (9) 
recorded the case of a person in Brazil who contracted a fatal infection with yellow 
fever 5 months after vaccination with monkey tissues treated with formalin  and 
phenol.  In March, 1931, a commission of the French Academy of Medicine (10) 
announced its conclusion that no method of vaccination  against  yellow fever had 
been sufficiently studied for use in practice. 
Attenuation  of Virus in Monkey Serum.--In this laboratory vaccination experi- 
ments with attenuated virus were carried out in 1929 and 1930 with the collabora- 
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tion of N. Paul Hudson.  The virus in highly infectious monkey serum was pro- 
gressively attenuated by exposure (a) to a temperature of 37°C., (b) to the effects of 
added formaldehyde (0.05,  0.1, or 0.2 per cent) or tricresol (0.3 per cent) at room 
temperature, or (c) to the effects of 0.3 per cent tricresol at a temperature of 37°C. 
or 0.5°C.  Portions of the serum under treatment were withdrawn at intervals for 
testing.  Some of these portions were injected at once subcutaneously into mon- 
keys.  Others were dried in the frozen state in test-tubes or ampoules by methods 
described in a previous publication (11), and stored for a week or more before injec- 
tion into monkeys.  Later the monkeys were given test inoculations of virulent 
yellow fever virus of the Asibi strain.  The periods of exposure of the vaccine to 
the attenuating agents varied in the different experiments, but commonly ranged 
from an hour or less to several days.  As a rule the vaccines exposed for the short- 
est periods to the attenuating agents produced yellow fever in the monkeys inocu- 
lated and the specimens long exposed failed to immunize.  Between these extremes, 
there were found in some cases exposures which attenuated the virus to such an 
extent that the vaccinated animals showed  no fever but acquired an active im- 
munity.  This zone in the series of exposure times was inconstant and narrow. 
The irregular results convinced us that much further research would be neces- 
sary if a safe and dependable vaccine for human beings was to be prepared by the 
chemical treatment of virulent strains of yellow fever virus. 
Simultaneous Injection  of Virus and Immune Serum.--The practice of injecting 
virus and immune serum at the same time but in different places has been followed 
in vaccinating swine against hog cholera and  cattle against rinderpest, and  in 
immunizing against other diseases of animals.  It is possible to immunize against 
at least one of these diseases, hog cholera, when the virus and serum have been 
mixed before injection, for Duval (12) has shown that the dried virus and the dried 
immune serum may be mixed, stored, and used together without the loss of anti- 
genic power. 
Many who, like ourselves, have had occasion to make protection tests of serum, 
using monkeys, have observed the presence of active immunity in those animals 
which have been protected against an injection of yellow fever virus by a  simul- 
taneous or previous injection of immune serum.  This observation (Theiler and 
Sellards (13), Findlay and Hindle (14), AragAo (15)) has suggested the possibility 
of using the same general method in vaccinating man. 
In one of our early experiments a solid active immunity was produced by mix- 
ing yellow fever virus of the potent Asibi strain in monkey serum,  dried under 
vacuum in the frozen state and redissolved, with similarly dried immune monkey 
serum, and injecting the mixture subcutaneously into monkeys.  The immunity 
was acquired in the absence of fever.  Although the serum and virus were in con- 
tact  for  30  to  40  minutes  at  room  temperature,  thorough  immunization  was 
accomplished when the amount of immune serum in the mixture was 5 or 10 times 
the minimum necessary to protect against the virus. 
It seemed to us that it would be a valuable safeguard if the living yellow fever 
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lower virulence for man than the strains now being carried in monkeys.  In vac- 
dnation against hog cholera, according to information given us by Dr. R. E. Shope, 
on rare occasions there occur unexplained failures of the immune serum to protect 
against the virus and as a result the vaccinated animals die of the disease. 
Attenuation  of Virus in Movze-Brain Tissue.--When Theiler  (16)  showed that 
yellow fever virus which had been adapted to mice had lost much of its virulence 
for monkeys, the hope was raised that the untreated virus in mouse-brain tissue, 
after enough passages in mice, would lose its virulence for man and would be safe 
to use as a vaccine.  At the time of our experiments the French strain of yellow 
fever virus had been through over 100 successive passages in mice and was never- 
theless still able to produce fever in monkeys, although it had apparently long lost 
its power to kill them.  Among 9 rhesus monkeys which were inoculated with this 
strain, after 102 to 120 passages through mice, and were afterward given test inocu- 
lations with virus from monkey source, 8 developed fever and all 9 were  subse- 
quently found to be immune.  Attempts were made to transfer the infection from 
4 of these animals to normal monkeys by inoculation with blood taken at the begin- 
ning of fever, but none of the animals receiving the blood developed fever; half of 
them were afterward shown to be susceptible, and the others immune, to yellow 
fever virus from monkey source (Asibi strain).  Two control monkeys inoculated 
with normal mouse-brain tissue remained free from fever. 
The gradual diminution of virulence for monkeys as yellow fever virus is passed 
through mice is illustrated  by our experience  with  the Asibi strain.  A  monkey 
inoculated with virus of the 5th passage in mice died of yellow fever.  Of 2 mon- 
keys inoculated with virus of the 10th passage, 1 died of yellow fever and the other 
had  fever  followed by  immunity.  One  which  received  the  llth-passage  virus 
died of yellow fever.  Monkeys inoculated with  virus of the 15th, 20th, and 25th 
passages developed fever and were immunized.  The French strain in  the  176th 
passage in mice still produced definite attacks of fever in monkeys. 
There is other evidence of the persistence of a degree of virulence  for monkeys 
and man in yellow fever virus after many passages through mice.  Sellards  (17) 
has shown that  such virus will  cause encephalitis  in monkeys if injected  intra- 
cerebrally.  Moreover, there are on record 3 mild cases  of yellow fever contracted 
by persons through contact with experimentally infected mice or their  tissues (1). 
Yellow fever virus after 100 or more passages in mice is probably of low virulence 
for man, but  still  capable of causing mild  attacks  of yellow fever.  If  used in 
vaccinating persons, it seems advisable, therefore, that the virus be attenuated or 
given with a potent immune serum. 
Two methods of attenuating the virus in mouse brain were tried, those of Scruple 
(18)  and  Alivisatos  (19)  for preparing  antirabic  vaccine.  Modifications  were 
necessary, and in some instances  the vaccine was dried in the  frozen state and 
stored before use.  The vaccine of the Semple  type, as prepared  and adminis- 
tered  to monkeys,  was  apparently  devoid of immunizing power.  That  of the 
Alivisatos type produced fever and immunity in monkeys when the brain tissue 
had been exposed to ether at 0.5°C.  for 6 or 24 hours, but  was inert when  the 
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Vaccination  with  Living  Yellow Fever  Virus  Fixed for  Mice  and 
Immune Human Serum 
The  preliminary  experiments  with  various  ways  of  vaccinating 
against  yellow fever seemed  to  show  that  the  most  dependable  and 
effective of the methods tried was the injection of living yellow fever 
virus  with  a  simultaneous  or  preceding  injection  of potent  immune 
serum.  Moreover,  it  appeared  that  yellow fever virus,  after many 
passages through mice, had lost most, but not all, of its  virulence  for 
monkeys,  and  probably  for  man,  although  retaining  its  power  to 
immunize.  It was proposed, therefore, to test in monkeys the safety 
and the immunizing power of a  vaccine composed of living virus fixed 
for mice and human immune serum, and, if these tests gave satisfactory 
results, to commence immunizing persons exposed to yellow fever. 
Preparation and Administration of the Vaccine 
The vaccine used throughout the experiments and in vaccinating people con- 
sisted of two parts, (a) the virus in mouse-brain tissue suspended in a portion of the 
immune serum or in normal serum, and  (b) immune human serum for separate 
injection.  In  many  experiments,  however,  both  parts  were  combined.  The 
description which follows gives the technic used in making most of the lots of the 
vaccine employed in immunizing persons, and at the end there is a statement of 
ways in which the preparation of the first vaccines, Vaccines A, B, 1, and 2, and the 
last,  Vaccine  6,  differed  from the description.  The essentials  of the method of 
preparation of each vaccine used are given in Table I. 
The Component Containing Virus.--The  virus used in the preparation of the 
vaccines was of the French strain, 105th to 176th passages in mice.  Only persons 
immunized against yellow fever by illness or vaccination were allowed to work with 
the virus.  A  10 per cent suspension  of the infectious mouse-brain tissue in im- 
mune serum was centrifuged for ½ hour at about 3,000 R.P.M.  The supernatant 
fluid was then passed through a Seitz filter.  As tests of sterility sets of aerobic and 
anaerobic cultures in slightly alkaline meat infusion  peptone  broth  were made 
before and after filtration.  The filtrate was placed in amounts of 1 cc. in sterile, 
plugged test-tubes and was dried in the frozen state under vacuum.  The tubes 
were then sealed in the blast lamp and stored in the refrigerator. 
Some of the vaccine, redissolved in distilled  water, was injected intraeerebrally 
into 6 susceptible white mice in amounts of 0.03 cc. and intraperitoneally into 4 
mice in amounts of 0.2 cc.  In all cases some of the mice given intracerebral injec- 
tions died of yellow fever encephalitis,  showing that there was living virus in the 
preparation.  The mice receiving intraperitoneal injections remained well.  At 
least 1 monkey was vaccinated with each lot of the material together with the 
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The Immune Serum.--The immune sera used for the separate injections at the 
time of vaccination, and  also in suspending the virus in the preparation of the 
vaccine, were obtained from 6 members of the laboratory staff who had had yellow 
fever as the result of accidentallaboratory  infections (1), and from 3 other members 
who had been immunized by vaccination during these studies.  Blood was with- 
drawn, defibrinated, and cleared of cells by centrifuging.  Aerobic and anaerobic 
TABLE  I 
Method of Preparation of the Vaccines Used 
Designa- 
tion of 
vaccine 
A 
B 
1 
2 
3 
4 
5 
6 
Strain of virus used 
and No. of passages 
ha mice 
French--105 
French--106 
French--107, 116! 
French--ll7 
French--146 
French--168 
French--174 
French--176 
Human serum in 
which virus was 
suspended 
Pe! centt 
of ",irus  ~ 
S11! l~nsl 
No. 3, immune  10 
No. 3, immune  10 
No. 1, immune  1, 2.5, 
No. 2, immune  10 
Pool A, immune  10 
No. 4, immune  10 
No. 5, immune  10 
No. 6, normal  I  10 
~e 
in  Filter used 
~n 
Not  fil- 
tered 
Not  fil- 
tered 
5  Not  fil- 
tered 
Berkefeld 
N 
Seitzl] 
Seitz 
Seitz 
Seitz 
Fresh or 
dried 
Freshet 
Dried 
Dried 
Dried 
Dried 
Dried 
Dried 
Dried 
Dried 
Mortality 
ratio ha 
micet 
9/12 
6/1x 
7/18§ 
3/12 
9/11¶ 
3/4 
12/12 
6/6 
* Fresh mouse-brain tissue containing yellow fever virus. 
t  Mice were  inoculated  intracerebraUy.  The  ratio  shows  the  proportion  of 
mice dying from 4 to 10 days after inoculation. 
When 3  weekly injections of this fluid vaccine were given, the 2nd and 3rd 
doses were freshly prepared by the same method but with new lots of virus.  This 
vaccine was fresh in Experiment I and dried in Experiment IV (Table II). 
§ Mortality ratio  for  1  per cent  virus, 2/6;  for 2.5 per  cent,  1/6;  for 5  per 
cent, 4/6. 
1] Part through Berkefeld N, part through Seitz. 
¶  The brain of 1 mouse was examined microscopically, and lesions of yellow 
fever encephalitis were found. 
cultures in broth were made as tests of sterility.  To the serum for use in the sepa- 
rate injections was  added 0.2  per cent of tricresol  in  ether,  by the method  of 
Krumwiede and Banzhaf (20).  Each serum was tested for potency by injecting it 
subcutaneously into rhesus monkeys in amounts of 0.3 cc, or more per kilo of body 
weight  and  thereafter  injecting 0.4 cc. of monkey blood containing yellow fever 
virus of  the Asibi strain, virulent for monkeys, under the skin in another place. 
Amounts of serum which protected the animals against yellow  fever were considered 
suitable for use in the same dosage per kilo in vaccinating man. 950  YELLOW  FEVER  VACCINATION 
Serum  !  consisted of several lots from W. A. S., who had been infected from 
monkey source.  This serum had a titre of 1/128 when tested in mice by the intra- 
peritoneal protection test (21).  Serum 2 (titre, 1/256)  from M. T. and Serum 3 
(titre, 1/128)  from S. F. K. came from persons who had been infected with virus 
from mice.  The donor (K. S.) of Serum 4  (titre, 1/25d) had been infected with 
virus from monkeys.  L.M.M.,  the source of Serum 5  (titre, 1/128), had been 
immunized by vaccination.  Serum 6 was normal serum without protective power. 
The blood of each donor had been found to give a negative Wassermann reaction. 
Serum Pool A (from W. L., K. S., and T. N.), Pools I and 2 (W. A. S., S. F. K., 
M. T., T. N., and K. S.), and Pool 3 (W. A. S., S. F. K., M. T., and T. N.) were 
made up of sera from persons who had experienced attacks of yellow fever.  Pool 
2, in the amount of 0.3 cc. per kilo of body weight, protected a monkey against the 
Asibi strain.  Pool 3  did not protect either of 2 monkeys when injected in the 
amount of 0.4 cc. per kilo of body weight.  It protected when used in the amount 
of 0.5 cc.  Pool 4 (titre, 1/256) was a mixture of the sera of 2 vaccinated persons, 
M. H. and L. B.T.  When injected d hours before the virus, this serum protected 
only ! of 2 monkeys in a dosage of 0.3 or 0.4 cc. per kilo, but it gave protection in 
the dosage of 0.6 or 0.8 cc. per kilo. 
Deviationsfro~ the Technic Described.--In  preparing Vaccines A, B, and 1, the 
suspension  of  brain  substance  in  immune  serum  was  neither  centrifuged  nor 
filtered.  Vaccine 1 was prepared in 3 strengths containing 1, 2.5, and 5 per cent of 
brain tissue, respectively.  Vaccine 2 was filtered successively through Berkdeld 
cylinders V and N, instead of through the Seitz filter.  In preparing Vaccine 6, 
the virus-containing mouse-brain tissue was suspended in normal human serum 
instead of in immune serum,  and the vaccine was dried in ampoules in 0.5  cc. 
amounts instead of in test-tubes in amounts of 1.0 cc. 
Administraion of the Vacdne.--In the vaccination experiments in which mon- 
keys were used, all the serum and the virus were given as a mixture except in a few 
instances, in Experiments VIII and IX, in which supplementary serum was given 
immediately before the injection of the component containing the virus.  In vac- 
cinating persons, on account  of the large volume of serum  required,  the usual 
method was to inject immune serum subcutaneously in 2 or 3 places on the abdo- 
men, and to inject the virus-containing component of the vaccine, redissolved in 
sterile distilled water,  subcutaneously at another point on  the abdomen.  The 
actual time interval between injections of serum and virus component was less than 
5 minutes in Cases 4 and 9 to 12 (Table IV); about 30 minutes in Cases 1 to 3 and 
5 to 8; and 6 hours in Cases 13 to 16. 
Tests for Hypersensitivity to Mouse-Brain  Tissue.--In 14 cases, all except Cases 
4 and 16, a preliminary intradermal injection of 0.1  cc. of a suspension of mouse 
brain in human serum was given ½  hour or more before the injection of the virus 
component of the vaccine for the purpose of detecting any unusual sensitivity to 
mouse-brain tissue.  1 per cent suspensions, especially if filtered, produced only 
slight transient reactions.  In the light of this experience and the observation that 
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of the spinal cord or brain tissue of rabbits in antirabic treatment it was decided 
that the preliminary intradermal test was unnecessary. 
Vaccination of Monkeys 
Nine experiments in the vaccination of rhesus monkeys with mixtures 
of virus fixed for mice and immune human serum were performed with 
the vaccine preparations and sera already described.  The results are 
brought together in Tables II and III. 
Most of the animals showed no reaction to the vaccination during an observa- 
tion period of at least 30 days.  Some had rises of temperature to 40°C. or above, 
which are recorded in Tables II and III as fever.  The temperatures of the mon- 
keys were taken twice each day, and the tissues of animals that died were examined 
histologically.  Blood drawn long enough after  vaccination to rule out passive 
immunity was tested in monkeys or mice, or in both, for its protective power 
against yellow fever virus.  Each vaccinated monkey was later given a test inocu- 
lation of virulent virus of Asibi strain from monkey source. 
In Experiment IV (Table II) fresh immune serum (Serum 3) was added to the 
redissolved  vaccine to give the required percentage of virus, and in Experiment 
VII, Vaccine  2 was similarly diluted with Serum 1.  In experiments VIII and 
IX (Table III) supplementary serum was given in separate subcutaneous injec- 
tions when the smaller quantities of virus were used. 
Experiments by Bauer (22) enabled us to rule out passive immunity in all the 
experiments except No. VII.  Monkeys which had received much larger amounts 
of human yellow fever immune serum in his experiments had lost their passive 
immunity within 14 days.  Passive immunity could not have been present even in 
the first 8 days of Experiment VII, for in human vaccinations, to be discussed 
later, it was shown that amounts of serum, equal to those given to monkeys in 
these experiments, produced no passive immunity that could be detected a few 
hours after vaccination. 
When the sera of vaccinated animals were tested in monkeys, the serum was 
injected intraperltoneaUy in the amount of 1.5 cc. per kilo in Experiments I and 
II, and 3 cc. per kilo in Experiments III and V.  6 hours later each of these mon- 
keys and at least 1 control were given subcutaneous injections of 0.4  cc. of the 
Asibi strain of yellow fever virus in monkey blood. 
In the tests of the serum in mice, and in all titrations, the technic of the intra- 
peritoneal protection test of Sawyer and Lloyd (21) was followed. 
The interval between vaccination and test inoculation with the Asibi strain was 
40 days in Experiments I and II, 76 days in Experiments III and IV, 45 days in 
Experiment V, 73 days in Experiment VI, 47 days (Monkeys 29 and 31) and 92 
days (Monkeys 30 and 32) in Experiment VII, 55 days in Experiment VIII, and 38 
days in Experiment IX. TABLE  II 
Res~ls of Vaccination  of l~es~ Monkeys wit~ Yellow F=er Virus Fixed for Mice 
and Immune Serum 
2-v 
i  i  ° 
~  8  ~.~.~ ,~  .~.~ 
ce~t  CC. 
I  1  A  l0  0.1 
2  A  10  0.1 
3  A  10 
4  A  I0 
II  5  B  10 
6  B  10 
III  7  t  1 
81  1 
91  1 
l0  1 
11  1 
12  1 
13  1 
14  1 
IV  15  A  5 
16  A  5 
17  A  5 
18  A  l 
19  A  1 
V  20  I 
21  1 
22  1 
VI  23  2  I0 
24  2  tO 
25  2  l0 
26  2  10 
1  Fever 
3  Fever 
1.0  1  No reaction  No reaction 
1.0  3  No reaction  No reaction 
days 
No reaction  35  Partial protec- 
tion 
No reaction  35  Partial protec- 
tion 
35  No protection 
35  No protection 
No reaction  40  Protection 
Died;  not  40  No protection 
yellow 
fever 
66  No protection 
66 
66  Partial  protec- 
tion 
No protection 
Protection 
Protection 
Protection 
Protection 
1.0  3  Fever 
1.0  3  Fever 
0.3  1  No reaction  No reaction 
0.3  1  No reaction  No reaction 
0.3  3  No reaction  No reaction 
2.5  0.3  1  No reaction  No reaction 
2.5  0.3  3  No reaction  No reaction 
5  0.3  1  No reaction  No reaction 
5  0.3  1  No reaction  No reaction 
5  0.3  3  Fevert  No reaction 
0.3  1  No reaction  No reaction 
0.3  3  No reaction  Died;  coli- 
tis~ 
0.3  3  Fever  Died;  coli- 
tis~ 
0.3  1  No reaction  No reaction 
0.3  3  No reaction  No reaction 
2.5  0.3  1  Fever  No reaction 
2.5  0.3  2§  No reaction  No reaction 
2.5  0.3  3§  No reaction  No reaction 
0.3  1  No reaction  Fever 
0. I  1  Fever  No reaction 
0.3  2  No reaction  No reaction i 
0.3  3  Fever  No reaction 
Control  27  2a][  10  0.3  1  No reaction  No reaction 
Control  28  2b¶  0  0.3  1  No reaction  Died;  yel- 
low fever 
VII  29  1  1  0.3  l  No reaction  No reaction 
30  1  1  0.3  1  Fever  Fever 
31  2  1  0.3  1  No reaction  No reaction 
32  2  1  0.3  1  No reaction  No reaction 
Tests of monkey serum 
S2 
~.~ ~  in monkeys,  test in mice. 
Result* 
66 
66 
66 
69 
69 
69 
69 
69 
69 
69 
40 
40 
40 
73 
73 
73 
73 
73 
8 
8 
8 
14 
Protection  test  Protection 
Result 
Protection 
No  protec- 
tion 
Inconclusive 
Inconclusive 
Inconclusive 
Protection 
Protection 
Inconclusive 
Protection 
Protection 
Protection 
Protection 
Protection 
Protection 
Protection 
Inconclusive 
Protection 
Inconclusive 
Protection 
Protection** 
Protection 
Protectiontt 
* "Protection" signifies that the monkey was free of fever and survived; "partial pro- 
tection," fever and recovery; "no protection," death from yellow fever. 
t  One rise of temperature a few hours after 2nd injection.  No other fever. 
~: Died 23 days after vaccination.  No evidence of yellow fever. 
§ Second injection consisted of only 0.1 cc. of the serum-virus mixture per kilo of body 
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From the experiments in the vacdnation of monkeys (Tables II and 
1H), the following facts seemed to emerge. 
1.  The monkeys which received a dried mixture of 0.003 to 0.03 gm. 
of yellow fever virus fixed for mice and 0.3 cc. of immune human serum 
per kilo of body weight, with or without additional inoculations of 
virus and serum, were immunized against yellow fever, and most of 
them developed demonstrable antiviral substances in their blood. 
TABLE  III 
Vacdnagon  of Monkeys wia, a Constant Amount of Immune Serum and  Varying 
Amounts of Virus 
.i 
VIII 
IX 
6  d 
Z 
33  3 
34  3 
35  3 
36  3 
37  4 
38  4 
39  4 
404 
1 
1 
I 
1 
¢¢.  g~ll. 
0.3f  O.O03t 
~).3  0.003 
~.3  0.001 
D.3  0.0003 
0.3~0.03 
0.3  o.oo3t 
0.3  0.0003 
0.3  0.00003 
i 
None 
None 
Fever 
None 
None 
Fever 
None 
Fever 
7o 
Not done 
Fever 
No reaction 
No reaction 
No reaction 
No reaction 
No reaction 
Fever 
Results of protection tests in mice 
Days between 
vaccination 
and bleeding* 
7  14  21  24 
±  +!  + 
-  + 
-  +  + 
-  + 
~-++! 
+++l 
±++ 
±  + 
Titre of serum 
of monkey 
24thday,  1/256 
28th day, 1/128 
28th day, 1/128 
28th day, 1/64 
28th day, 1/64 
*  +  signifies "protection;" ~, "inconclusive;" --, "no protection." 
The amount most commonly used in vaccinating persons. 
:~ In this amount Serum Pool 3  was found to have too low a  protective power 
against Asibi virus from monkey source for use in vaccinating persons. 
weight; 3rd injection, 0.1  cc. of 5 per cent fresh virus (mouse-brain)  in normal human 
serum per kilo. 
[I Normal human serum used in place of immune serum. 
¶  Immune serum without virus, to rule out persistence of passive immunity in tests of 
serum of vaccinated monkeys. 
** Titre of serum by protection test in mice on 56th day after vaccination was 1/512, 
the highest dilution tested. 
tt 8 days after vaccination the result was "no protection." 954  YELLOW  FEVER  VACCINATION 
Of 23 such monkeys (Table II, Experiments III to VII, excluding  Monkeys 24, 
27, and 28), 18 had no reaction during the observation  period of 30 days, and 5 had 
rises of temperature to 40°C.  All were given test inoculations  with virulent yellow 
fever virus of the Asibi strain.  Two died of ulcerative colitis without any evidence 
of yellow fever.  The other 21 survived.  The sera of 7 of these 23 vaccinated 
monkeys were tested in monkeys for protective power: 4 protected completely, I 
permitted fever, and 2 gave no protection.  The sera from 20 of the 23 vaccinated 
monkeys  were tested in mice: 14 of the sera protected, 5 gave inconclusive  results, 
and I gave no protection. 
2.  One injection of the vaccine was as effective in the production of 
~mraunity as 2 or 3 weekly injections (Table II). 
3.  The immunizing power of the vaccine did not vary significantly 
with its virus content, although the amount of the virus-containing 
brain tissue ranged from 0.00003  gin. per kilo of body weight to 0.03 
gm., the largest amount being 1,000  times the smallest (Table III). 
4.  Antlviral substances, sufficient in amount to be detected by the 
protection test in mice, were sometimes present in the blood of mon- 
keys as early as 8 days after vaccination (Table If, Experiment VII). 
5.  The few vaccinated monkeys whose serum had not acquired the 
power definitely to protect monkeys or mice against yellow fever virus 
were nevertheless resistant to test inoculation. 
6.  As symptoms following vaccination were absent or slight, this 
method of immunizing was safe for monkeys and probably would be 
harmless to persons. 
Vaccination of Persons 
Sixteen persons were vaccinated against yellow fever in this labora- 
tory,  the  first on  May 13,  1931,  by the methods developed in the 
experiments with monkeys.  In addition, 3  persons  in Nigeria and 
Brazil have been immunized effectively with materials sent from this 
laboratory.  The essential facts regarding the vaccinations performed 
by us are shown in Table IV. 
The preparation of the vaccines has been described in the preceding text and 
Table I.  In Cases 1 to 4, 11, and 12, the virus suspension  had not been centrifuged 
or filtered.  In Case 4 most of the immune serum (16 cc.) had been dried with the 
virus and the additional 5 co. needed had been dried in the frozen state 2 months 
before.  In the other cases the immune serum for separate injection had been tri- 
cresolized and stored as fluid. W. A.  SAWYER,  S. F.  KITCHEN,  AND  W. LLOYD  955 
Although the dried specimens of Vaccine 1 used in Cases 11 and 12 had been 
stored for nearly 8 months in the refrigerator, they still had high irnmu]3izing 
TABLE  IV 
Results  of  Vaccination  of Persons  with  Yellow  Fever  Virus  Fixed for  Mice and 
Immune Serum 
No. of  Person 
cane  vacdnated 
D. B. W. 
E.H. 
L. B. T. 
V.G. 
T. P. H. 
L. M. M. 
N.R. 
P.  J. C. 
G. W. M. 
J. P. C. 
j. s. c. 
M.H. 
J. H. B. 
C. R. E. 
H. E. H. 
i  J.H.P. 
Tests of person's serum for protective 
power 
In rhesus 
In white mice  monkeys  Amount  Amount 
of virus  of 
No. of  No. of  per kg.  immune  Interval from  Interval from 
vaccine i  serum  of body  serum  vaccination to  vaccination  to 
weight  pet kg. 
1  1 
1  1 
1  1 
1  1 
2  1 
2  1 
2  1 
2  1 
3  1 
3  Pool 1 
1  Pool 2 
1  Pool 1 
4  1 
4  1 
4  1 
6  Pool 4 
Iatst negative  Last  Ist posi 
(--} or incon-  1st  negative  tlve~ 
chsive(±~  positive  resultt 
result* 
gin.  ¢c.  days  days  days  days 
0.003  0.3  7 (±)  9  0  19 
0.003  0.3  8 (±)  14  ~  0  23 
0.003  0.3  8 (±)  14  7  23 
0.003  0.3  8 (-)  12  0  15 
0.003  0.3  7 (-)  14  14  23 
O.OO3  0.3  7 (--)  14  --3  14 
0.003  0.3  7 (--)  14  14 
0.003  0.3  12 (±)  21  89 
0.003  0.3  6 (±)  9  -6  89 
0.003  0.3  -3(-)  i  7  84 
0.0015  0.3  7 (±)  ~  10  --4§  34 
0.001  0.3  0 (--)  7  O§  36 
o.o03  0.3ll  7 (-)  lX 
9.003  0.3l[  7 (±)  11 
0.003  0.3511  10 (-)  14 
~.o008  0.611  17 (±)  21 
* When inconclusive  results are shown, there was an earlier negative result. 
t  Two monkeys were used in Case 5, in other cases only 1.  Numbers preceded 
by minus signs show the number of days before vaccination. 
Two test monkeys were used in each case.  Control monkeys receiving virus 
and normal serum died of yellow fever. 
§ In an additional test 21 days after vaccination 1 monkey survived and 1 died 
of yellow fever. 
II Serum given 6 hours before the virus component. 
power.  This evidence and the observation (Table III) that even one one-hun- 
dredth of the usual amount of virus would produce strong immunity in monkeys, 
led us to fix the quantity of virus to be used in vaccinating human beings, irrespec- 956  YELLOW  :FEVER  VACCINATION 
tive of weight, beginning with Case 16, as that which is present in 0.5 cc. of a 10 
per cent suspension of infective  mouse brain in normal human serum after filtration 
through a Seitz disc and storage in the dried state in the refrigerator for not more 
than 6 months.  A man weighing 70 kilos, for example, would now receive only 
0.0007 gm.  of mouse brain per kilo,  minus the loss by filtration.  While  body 
weight  would no longer determine the amount of virus, it would still decide the 
amount of immune serum. 
Symptoms after  Vaccination 
The first person to be vaccinated was admitted to the Hospital of 
The Rockefeller Institute for Medical Research through the courtesy 
of Dr. Rufus Cole and Dr. T. M. Rivers, and was closely observed for 
us by Dr. G. P. Berry of the hospital staff.  Six hours after vaccination 
there was decided tenderness in the abdominal wall where the unfiltered 
virus  component of the  vaccine had  been injected,  but  none where 
serum alone had been given.  The tenderness disappeared in 2  days. 
There were no subjective symptoms and no abnormalities of tempera- 
ture, pulse, blood pressure, heart action as shown by electrocardiogram, 
or  urine,  during  10  days  in  the  hospital,  2  before  vaccination  and 
8 after. 
The other persons vaccinated remained on duty in the laboratory. 
Outside the hospital the vaccinated persons took their own tempera- 
tures at intervals of 4 hours during the day for a period of 2 weeks and 
recorded  any  subjective  symptoms.  The  symptoms  following vac- 
cination  were  few  and  may  be  briefly  summarized  in  4  groups  as 
follows: 
1.  Early Reactions to the Injected Mouse-Brain  Tissue.--These symptoms were 
most in evidence during the evening following vaccination, and they disappeared in 
from 1 to 3 days.  They were (a) tenderness at the site of injection of the virus 
suspension, sometimes with slight redness and swelling, and (b) rises of temperature, 
with headache or dull pain in the back or legs in 3 instances.  Tenderness was pre- 
sent in all cases except Nos. 8, 12, and 16, and was severe in Cases 4 and 6.  In 
9 of the 16 cases the temperature rose above normal, but in only 1 didit go above 
37.4°C.  Except in Case 6, these early symptoms were slight or absent when the 
injected virus suspension had been filtered.  Leucocytosis  was commonly present. 
2. Symptoms  Suggestive of Late Reactions to the Injected Mouse-Braln  Tissue.-- 
(a)  7 days after vaccination, in Case 2, a lymph node near one of the sites of injec- 
tion of unfiltered virus suspension became slightly enlarged and tender.  On the W.  A.  SAWYER,  S.  F. XITCHEN~  AND  W.  LLOYD  957 
following day the skin at the site of the intradermal injection of the same suspen- 
sion became reddened a~d elevated in an area 1.5 by 2 cm. and was surrounded at 
a distance of a few centimeters by 6 small papules (2 by 3 cm.) topped by vesicles 
1 mm. in diameter.  1 day later similar papules appeared here and there on the 
arms and legs.  The temperature was 37.2°C. on the 8th and 9th days. 
(b)  7 days after vaccination, in Case 12, one of the sites of injection of unfiltered 
virus suspension became red and  slightly swollen,  and  the  temperature  rose  to 
37.2°C.  The swelling measured 4 by 5  cm.  It was not tender,  but  there was 
itching.  The swelling disappeared in 3 days. 
(c)  A mild attack of arthritis began 14 days after vaccination in Case 10.  The 
fever lasted 3 days.  There was tenderness for 4 days in several joints, including 
the  knees,  the  hips,  an  elbow,  and  the  temporomaxillary  articulation.  Blood 
taken on the 2nd day of fever and injected into a rhesus monkey did not immunize 
the animal against a later injection of yellow fever virus.  The vaccinated person 
had had a  similar attack of arthritis  11 months earlier,  and he has had another 
such attack along with a "cold" 5½ months after vaccination. 
(d)  13 days after vaccination, in Case 15, there was slight soreness of an ankle 
on motion.  (A similar condition in the right elbow was reported as being present 
in the ease of H. W. B. from 5 to 13 days after vaccination in Nigeria with Vaccine 
3 and Serum Pool 2.) 
In the 2 instances in which there were late reactions at sites of injection of the 
virus suspension,  the injected material had not been centrifuged or filtered and 
therefore contained tissue particles.  It seems probable that these inflammations 
of skin and lymph gland and also the arthritis were late reactions, of the serum 
disease type, to the injected foreign tissue.  According to Boots and Swift (23), 
serum sickness is manifested during the 2nd and 3rd weeks following serum treat- 
ment by fever, lymph node enlargement, urticaria,  transitory leucopenia followed 
by leucocytosis, and less frequently by joint pain and tenderness. 
3.  Symptoms Probably Having No Relation to the Vaccination.--In this group are 
included (a) rises of temperature following the extraction of infected teeth in Cases 
1 and 8, and (b) symptoms of "colds" in Cases 6, 11, 14, and 16. 
4.  Symptoms Possibly Related to the Virus Injected.--In this group are included 
symptoms which may have been due to an immunizing yellow fever infection held 
in check by immune serum, although some of them may have been late reactions to 
foreign tissue, like the symptoms mentioned under "2."  The leucopenia discussed 
in the following section should be classed with this group.  In Case 1, on the  llth 
day after vaccination there was chilliness,  and on the 12th, a rise of temperature to 
37.4°C. with headache.  In Case 6 there were rises of temperature to between 37.2 ° 
and 37.9°C. almost daily from the 8th to the 13th days.  In Case 7 the tempera- 
ture rose to 37.3°C. on the 8th day and headache and backache were present.  In 
Case 9 there was a rise to 37.2°C.  on the 10th day.  In Case 15 the temperature 
was 37.2°C.  on the 6th day after vaccination. 958  YELLOW  ~'EVER VACCINATION 
The Leucocytic Reaction to Vaccination 
To secure evidence on the nature of the ~mmunizing reaction to vac- 
cination and make possible comparison of the blood cell changes with 
those observed by Berry and Kitchen  (1)  in attacks  of yellow fever, 
the following study of the  blood of the  vaccinated  persons  was  car- 
fled out. 
Total leucocyte counts were made each forenoon, except for a  few omissions, 
beginning 2 or 3 days before vaccination.  The results are presented in Table V. 
The immediate reaction of the white blood cells,  observed 4 to 6 hours after the 
injection of the virus suspension, was in most instances an abrupt rise.  This was 
followed by a decrease, noticed the next morning.  Over the ensuing several days 
there occurred an additional and more gradual fall,  interrupted  occasionally by 
irregular rises,  until the count was in most cases below normal.  Of 16 persons 
vaccinated,  14 showed some degree of leucopenia between  7 and  10 days after 
vaccination.  In 5 cases the low point was below 4,000; in 5, between 4,000 and 
4,999; in 4, between 5,000 and 6,000.  In the remaining 2 cases it was over 5,000, 
but in 1 of them several counts were omitted. 
Differential white cell counts were made on the first 9 persons vaccinated.  They 
revealed no constant deviation from the normal in the ratios.  In 5 of the 9 cases 
there was an increase of neutrophiles a few hours after vaccination, at the height of 
the immediate reaction to the foreign tissue.  The leucopenia was due chiefly to a 
decrease in the number of neutrophiles.  The changes in the numbers of lympho- 
cytes and monocytes were not sufficiently consistent tobe significant. 
A degree of leucopenia was observed which was in general less than that seen in 
yellow fever, but the time of occurrence was consistent with that in yellow fever if 
allowance be made for an incubation period.  The time from vaccination to leuco- 
penia would seem to correspond approximately to the time between onset of illness 
and leucopenia, plus the incubation period. 
As leucopenia may occur in serum sickness (23), we considered the possibility 
that the low white cell counts observed after vaccination might be late reactions to 
the injection of foreign tissue rather than effects of the virus.  Against this inter- 
pretation is the observation that definite leucopenia was not observed in any of 
3 persons immune to yellow fever by reason of attacks of the disease,  who were 
inoculated with monse-brain tissue as controls, although they showed the usual 
immediate rise after the injection of the foreign tissue (Table V).  Two of these 
persons (S. F. K. and M. T.) received normal tissue and I  (W. A. S.) infective tis- 
sue.  The amount of brain tissue injected subcutaneously into W. A. S. and S. F. K. 
was approximately  the same as that given in Case 11  (0.0015  gm. per kilo), and 
the suspension was in immune human serum and was unfiltered.  To M. T. was 
given a filtered suspension in normal human serum containing 0.003  gin. of virus 
per kilo minus the loss by filtration.  The small number of these controls still left W.  A.  SAWYER~  S.  F.  KITCHEN~  AND  W.  LLOYD  959 
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some doubt as to the significance of the leucopenla,  and further evidence was there- 
fore obtained by making total white cell counts on monkeys. 
Four  monkeys which  received an  amount of filtered virus-containing mouse 
brain per kilo of weight equal to that most commonly used in vaccinating persons, 
showed a definite leucopenia with low points from 3 to 6 days after the injections. 
Two other monkeys given normal mouse brain and 1 control animal which was not 
inoculated,  showed irregular  fluctuations  in  white  cell counts,  but  no  definite 
leucopenia. 
The  evidence suggests  strongly that  the  leucopenia observed after 
vaccination is a  reaction to the virus rather than  to the mouse-brain 
tissue. 
The Immunity Produced by Vaccination 
The effectiveness of the vaccination of persons against yellow fever 
was  measured  by  carrying  out  intraperitoneal  protection  tests  with 
their serum in mice (21),  and in all 19 cases, including those of the  3 
persons vaccinated in Nigeria and Brazil with materials sent from this 
laboratory, a  substantial active immunity was demonstrated within a 
month after vaccination.  As is shown in Table IV the sera of the  16 
persons vaccinated in this laboratory acquired power to protect mice 
against yellow fever virus in from 7 to 21 days after vaccination.  The 
serum of each had failed to protect before vaccination. 
As the active immunity had been produced by injections of virus fixed for mice, 
it was important to find out whether the sera of the vaccinated persons would pro- 
tect also against strains of yellow fever virus other than those adapted to these 
animals.  The sera of the first  12  persons vaccinated were therefore tested  in 
rhesus monkeys against the Asibi strain of yellow fever virus from monkey source, 
a strain known to be virulent for monkey and man.  In every case the serum pro- 
tected each of 2 monkeys against death, and in most cases against fever also,  when 
injected intraperitoneally in the amount of 1.5 cc. per kilo of body weight. 
That passive immunity played no part in the observed protection by the sera of 
vaccinated persons was proved by testing the sera of the first 3 persons, by the pro- 
tection test in mice, approximately 2,  6,  and 24 hours after vaccination.  Two 
negative results and  1 inconclusive  result were obtained for each time interval. 
Moreover, in most cases, including Cases 15 and 16 in which the serum was given 
in larger dosage,  there was evidence against the presence of passive immunity in 
the negative and inconclusive  results between the time of vaccination and the first 
positive. 
The  rise of the  protective power of the  sera of vaccinated persons 
and  the  subsequent  fluctuations  were  followed by titration  in  mice. W. A. SAWYER~  S. ~F. KITCHEN~ AND  W. LLOYD  961 
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The results of the titrations  are brought together in Fig.  1.  We are 
indebted to  Dr.  T.  P.  Hughes  and  Dr.  M.  Hoskins for making  the 
titrations, and to Dr. J. S. Cunningham and Dr. J. H. Bauer for assist- 
ance in preparing the many serial dilutions required. 
For comparison,  the  titres of sera from persons  who have  passed 
through  attacks of yellow fever are  shown in  Fig.  1.  The  6  recent 
cases  are  mentioned  in  the  publication  by Berry  and Kitchen  (1). 
For the sera of the 3 early cases we are indebted to Colonel J. F. Siler, 
Chief Health Officer of the Canal Zone, and Dr. L. B. Bates, Chief of 
the Board of Health Laboratory, Canal Zone.  A.W.C.  had yellow 
fever in 1901 in Cuba in one of the experiments of the Army Commis- 
sion under Walter Reed.  J.H.S.  and J. C. had their attacks in the 
Canal Zone in 1905. 
From Fig. 1 and Table IV it appears that, as a rule, the protective 
antibodies became demonstrable by tests in mice during the 2nd week 
after vaccination and increased to a maximum in the following 2 or 3 
weeks.  After  that,  they  remained  at  about  the  same  level  for  at 
least  6  months,  most  of  the  titres  lying between  1/64 and  1/256. I 
The average titre was a little lower than the average for the sera from 
recent  cases of yellow fever,  but  the  difference may not  have  been 
significant in view of the small number of these recovered cases.  Of 
the sera from persons who had had yellow fever from 26 to 30 years 
ago, one had a  titre  at the  top of the range  for vaccinated persons, 
another's  titre was at the bottom of this range,  and the titre of the 
third was much lower. 
The Infectivity of the Blood after Vaccination 
If there were yellow fever virus in the blood of vaccinated persons 
during  the  process of immunization  and  the  mosquito  vector were 
present, there would be risk of transferring  the infection and starting 
an epidemic.  This risk would be serious if the virus were from monkey 
source, but would seem to be remote if it were the neurotropic strain 
fixed for mice.  Earlier in this paper we have mentioned the difficulty 
1  Since the completion of this article  titrations  of the sera  of 3 of the vac- 
cinated  persons have  been made  from 5 to  10 months  after vaccination.  In 
Case 6 a titre of 1/8 was obtained 27 weeks after vaccination.  In Cases 5 and 
11 uncompleted titrations  show that the titres  will be below 1/32. W.  A.  SAWYER,  S.  ~F.  KITCHEN~  AND  W.  LLOYD  963 
of carrying infection with the fixed virus from one monkey to another 
by the transfer of blood.  It is,  however,  theoretically possible  that 
the fundamental changes which have taken place in the virus during 
its adaptation to mice could be reversed under unusual conditions, and 
it cannot be too strongly urged that the living yellow fever vaccine 
virus should not be sent into regions in which yellow fever is absent 
but its vector is present, or introduced into other countries without the 
sanction of the government health authorities. 
To determine whether virus was present in  the blood of vaccinated 
persons several tests were made.  Dr. Max Theiler cooperated by mak- 
ing many of the tests in mice for infectivity. 
The intervals between vaccination and the taking of blood were 2, 6, 24, and 48 
hours in Case 1 ; 2, 5, and 24 hours in Case 2; 2, 5, and 24 hours, and 7 days in Case 
3; 3, 4, 6, and 7 days in Case 15; and 2 and 3 days in Case 16.  Each specimen was 
defibrinated and injected intracerebraUy into 12 or more highly susceptible mice. 
In most cases the blood was centrifuged and the serum injected into one set of 12 
mice and the washed  corpuscles into another.  In Case  16 only the serum was 
used.  In no case was virus recovered.  There were a few deaths which might have 
been due to the virus, but in those instances in which subinoculation  was possible 
or histological examinations  of the brain were made, the diagnosis of yellow fever 
was ruled out. 
In certain cases some of the blood was injected also into rhesus  monkeys: 10 
cc. of the washed blood cells of the 6-hour specimen in Case 1, and 3.5 co. of the 
defibrinated 4-day specimen and 5 cc. of the washed blood cells of the 7-day speci- 
men in Case  15.  Each of the 3 monkeys succumbed  later to test inoculation. 
Evidently they had not been immunized and the virus had not been present in the 
injected blood. 
It seemed clear that in every instance the virus was absent from the 
blood of the vaccinated persons tested, or at least was very small in 
amount.  On  account  of  the  remaining  uncertainty  the  following 
experiments in monkeys were undertaken. 
(a) A  rhesus  monkey was inoculated subcutaneously with 0.3 cc. of Vaccine 4 
per kilo of body weight.  It received in this way, on the basis of body weight, the 
usual amount of immune serum used in vaccinating persons, and 10 times the usual 
amount of virus.  Blood was taken for test 2 hours and 20 hours later, and each 
sample was injected intracerebrally into 24 mice, 12 of which received defibrinated 
blood and 12, serum.  The results were like those obtained in the tests of human 
blood.  Only a few mice died,  and in 1 instance subinocnlation excluded yellow 
fever as the cause of death. 964  YELLOW  FEVER  VACCII~ATION 
(b)  Two rhesus monkeys were inoculated  with the usual amount of virus but 
only one-tenth the usual quantity of immune serum.  The blood of one monkey 
was tested after 1, 3, 5, 7, and 9 days, and that of the other after 2, 4, 6, 8, and 10 
days.  In each test 12 mice were inoculated  intracerebrally  with serum  from de- 
fibrinated blood.  The specimens taken 2, 3, 4, and 5 days after inoculation of the 
monkeys caused heavy mortality in the mice, and the cause of death was shown to 
be yellow fever by subinoculation  and histological examination.  The virus was 
not recovered from the specimens taken after other periods. 
(c)  Of a  group of 4 rhesus monkeys,  2 were given subcutaneously  0.5  cc. of 
immune human serum per kilo of body weight.  3 hours later all 4 monkeys were 
inoculated subcutaneously with 0.03 cc. of Vaccine 6 per kilo.  In this vaccine they 
received  the usual  amount of virus,  but no immune serum.  Of the 2 monkeys 
which had received immune serum, one had no reaction  and the other developed 
fever.  From I to 7 days after vaccination each monkey was bled on alternate days, 
1 of each pair on the even days and the other on the odd days.  Twelve or more 
mice were inoculated  intracerebrally  with each blood specimen.  The mice which 
had received blood taken 1, 2, and 3 days after inoculation from the monkeys which 
had not been  given immune serum  showed a  high mortality, and the virus was 
recovered from each group of mice.  The virus was not recovered from the blood of 
the monkey which had received immune serum and virus and had shown no rise of 
temperature,  and there were very few suspicious deaths among the mice receiving 
this blood.  The mice inoculated  with blood from the monkey which had been 
given immune serum and virus but had nevertheless reacted by showing fever, also 
had a low mortality, but the virus was recovered from 1 mouse which had been 
given blood drawn 3 days after vaccination.  It seems that the virus was present in 
very small amounts in the blood of the monkey which had not been  completely 
protected by the immune serum.  Daily counts of the leucocytes in the blood of 
each of these 4 monkeys were made.  There was leucopenia in each case, with the 
lowest number of cells from 4 to 6 days after inoculation. 
In these tests we were unable to recover the virus from the blood of 
persons or monkeys vaccinated with fixed virus and sufficient immune 
serum  to prevent fever, but the virus was found to be  abundant  in 
the  sera of monkeys given fixed virus and much less than  the  usual 
amount  of  immune  serum.  Virus  was  present  in  extremely  small 
amount in the blood of 1 monkey which developed fever after receiving 
almost enough serum,  It is concluded that virus may circulate in the 
blood after vaccination if the amount of immune serum injected is not 
adequate,  and  that  this  dangerous occurrence may be  prevented by 
using immune serum in excess of minimal requirements. W.  A.  SAWYER~ S.  ~'.  KITCIKEN~ AND  W.  LLOYD  965 
The Nature of the Immunizing Reaction 
In our experiments it was shown that yellow fever virus  could be 
mixed  with  proportionately  large  quantities  of  immune  serum  and 
kept at room temperature during several hours of preparation without 
losing the power to produce a  substantial active immunity after injec- 
tion into monkey or man.  On superficial consideration this experience 
would seem at variance with the frequent observations of others that 
mixtures of viruses and large mounts  of immune serum are without 
immunizing power. 
J. H. Bauer (24), in an unpublished experiment cited with his permission,  kept 
5 per cent of yellow fever virus (infectious monkey serum) in immune human serum 
at 37°C. for 2 hours.  He then injected the mixture into 10 monkeys in amounts 
ranging from 0.001 to 3.0 cc.  There were no reactions, and all but 1 of the monkeys 
died later of yellow fever after test inoculation.  The virus in the mixture had 
evidently been completely neutralized and had lost its immunizing power.  In an- 
other experiment he showed that a mixture of 1 cc. of immune serum with 0.1 cc. of 
virus (infectious monkey serum), after exposure to room temperature in the African 
tropics for 45 minutes, would produce active immunity when injected into a mon- 
key, but that a mixture of the same amount of serum and only 0,01 cc. of virus 
would produce no immunity. 
To gain information about the extent to which neutralization might 
occur in the mixtures of virus and immune serum used by us in vac- 
cination, the following experiments were performed. 
Experiment A.--Two 10 per cent suspensions of the fixed yellow fever virus were 
made, one in normal human serum and the other in immune human serum.  They 
were centrifuged and filtered through a Seitz disc.  Each suspension was divided 
into two lots, one of which was kept at 28°C. and the other at 3°C.  The mixtures 
kept at 280C. were tested after 4, 24, and 96 hours, and those at 3°C. after 24 and 
96 hours.  In every test, a monkey was inoculated with 0.3  cc. of the suspension 
per kilo of body weight, and in all except the tests of the 4-hour specimens 0.03 cc. 
of the material was injected intracerebrally into each of 6 susceptible mice. 
All the monkeys which received mixtures containing normal serum and the one 
given the 4-hour spedmen containing immune serum became highly immune, for 
their blood serum developed a high titre for protective antibodies, ranging from 
1/64  to  1/512.  Moreover,  all  these  monkeys later survived test inoculation, 
except i  which  died of other cause than yellow fever.  Every mouse inoculated 
with the same mixtures died,  presumably of yellow fever.  The monkeys which 
received the mixture containing immune serum, after it had been exposed to tern- 966  YELLOW  ~"EVER  VACCINATION 
peratures of 28°C. or 3°C. for 24 hours or longer were not immunized, for all died 
of yellow fever after test injections,  and their serum failed to protect.  The mice 
inoculated with the same mixtures survived, except 1 in each of 2 sets. 
From this evidence it is apparent that the virus in a filtered 10 per cent suspen- 
sion of fixed virus in immune serum was not neutralized  in 4 hours at 28°C. but 
that it was entirely neutralized and inert after 24 hours at 28  ° or 3°C. 
Experiment B.--A filtered  10 per cent suspension of fixed yellow fever virus in 
normal monkey serum was divided into two parts.  To one was added an equal 
part of normal monkey serum and to the other an equal part of immune monkey 
serum.  In testing these mixtures in monkeys, 0.06 cc~ per kilo of weight was in- 
jected subcutaneously.  Each mixture was placed at 37°C. and tested immediately 
and after 0.5, 2, and 6 hours.  All the mixtures without immune serum, and also 
those which contained immune serum but which had been kept at 37°C. for 2 hours 
or less, produced immunity in monkeys and killed nearly all the mice inoculated 
intracerebrally.  But the mixture  of immune  serum  and fixed virus,  which had 
been kept at 37°C. for 6 hours, permitted all but 1 of the 6 mice inoculated to sur- 
vive.  Two monkeys injected with the same mixture survived  test inoculation, but 
the titres of their sera were low (1/32 and 1/64), while the titres of the sera of the 
other monkeys in the experiment were about 1/256.  One of the 2 monkeys showed 
the typical leucopenia and the other did not.  It appears  that the immune serum 
in this experiment had not neutralized  the virus in 2 hours but had neutralized  it 
almost, but not quite, completely in 6 hours. 
Experiment C.--In a third experiment the same basic 10 per cent suspension of 
fixed virus in normal serum was used as in Experiment  B, and equal volumes of 
varying dilutions  of the immune  monkey serum  used  in that  experiment  were 
added.  The final concentrations  of immune serum in the mixtures were 1/2, 1/8, 
1/32, 1/128, 1/512, and 0.  The mixtures were kept at 37°C. for 48 hours to per- 
mit maximum  neutralization,  and then each was injected  intracerebrally  into 6 
mice.  Mixtures with immune serum concentrations  of 1/32 or over permitted all, 
or all but 1, of the mice in each set of 6 to survive, but the mixtures with concen- 
trations of 1/128 or less, caused all, or all but I, of the mice to die.  It follows that 
the minimum concentration of the immune  serum  which would neutralize  the 5 
per cent content of fixed virus,  minus the loss by filtration,  in 48 hours at 37°C., 
lay between 1/32 and 1/128. 
From these experiments the following conclusions are drawn. 
(a)  Neutralization  of yellow  fever virus  by immune  serum  takes 
place very slowly at room temperature.  It must have been far from 
complete in  the mixtures  of immune serum  and virus used by us in 
immunizing man and monkey, and it must have ceased when the mix- 
tures were dried. 
(b)  When yellow fever virus is completely neutralized  by immune 
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(c)  The  injection  of a  mixture  of yellow fever virus  and immune 
serum,  under  the  conditions  of  our  experiments,  is  approximately 
equivalent to the simultaneous injection of the two components. 
The observation that the degree of immunity produced by vaccina- 
tion was almost as high as that following the naturally acquired disease 
was contrary to expectation, as it had seemed probable that an amount 
of immune serum capable of inhibiting symptoms would also limit the 
immunizing  reaction.  To  find  out  whether  extreme  quantities  of 
serum  would prevent  or  diminish  the  production  of immunity  the 
following experiment was performed. 
A monkey was inoculated subcutaneously with 6 cc. of immune monkey serum 
per kilo of body weight and 1 hour later it was inoculated subcutaneously with 0.06 
co. (per kilo) of the same 5 per cent filtered suspension of fixed virus in normal 
monkey serum aswas used in Experiment B.  The amount of immune serum was 20 
times the usual amount used in vaccination and corresponded to 420 cc. for a man 
weighing 70 kilos.  14 days after the injections, when passive immunity was still 
present,  the protective power of the monkey's serum was low (titre,  1/16), and 
62 days after the injections the serum protected only when tested in full strength 
(titre,  1/1).  Daily leucocyte counts showed that the usual leucopenia did not 
occur.  Elevations of temperature were observed and attributed to the excessive 
amount of serum injected.  A test inoculation of virus of the Asibi strain was given 
73 days after the injections, when some passive immunity was probably present. 
The monkey survived. 
The  injection  of extremely large  amounts  of immune  serum  may 
greatly diminish,  and perhaps  prevent,  the production  of protective 
antibodies in the blood after injections of yellow fever virus. 
The  minimal  amount of immune  serum,  per kilo of body weight, 
which will protect monkeys against the highly virulent Asibi strain of 
yellow fever virus appears, from our experience, to be also the minimal 
amount  needed for protection of men or monkeys against  the  fixed 
strain having low virulence for them. 
S~ARY  AND  CONCLUSIONS 
1.  After  preliminary  experiments  in  monkeys,  15  persons  were 
actively immunized by a  single injection of a  dried mixture  of living 
yellow fever virus,  fixed for mice,  and human  immune  serum,  with 
separate injections of enough additional  serum to make up the amount 
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2.  One person was similarly immunized by injecting immune  serum 
and dried virus separately. 
3.  By  titration  of the  sera  of  vaccinated  persons  in mice,  it  was 
shown that the immunity rose in a  few weeks to a height  comparable 
to that  reached  after an attack  of yellow fever,  and  remained  there 
throughout an observation period of 6 months. 
4.  Yellow fever virus could not be recovered from the blood of vac- 
cinated persons or monkeys, except when the latter had  received  less 
than the minimal effective amount of immune serum. 
5.  Neutralization of yellow fever virus by immune serum took place 
very slowly in vitro at room temperature in our experiments, and could 
not have  been  an  appreciable  factor in  vaccination  with  the  serum 
virus mixtures. 
6.  A mixture of fixed virus and immune serum retained its immuniz- 
ing power for 8  months when dried in the frozen state and  sealed in 
glass. 
7.  It appears that the immunizing reaction after yellow fever vac- 
cination was a part of a true infectious process, as was also the observed 
leucopenia. 
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